查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601019

肝病診斷市場：按診斷方法和最終用戶分類 - 全球預測 2025-2030

Liver Disease Diagnostics Market by Diagnosis Technique (Biopsy, Endoscopy, Imaging), End-user (Hospitals, Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肝病診斷市值為99.4億美元，預計2024年將達到110.9億美元，複合年成長率為12.76%，預計到2030年將達到230.5億美元。

肝病診斷市場專注於診斷肝病的工具和測試，包括肝炎、肝硬化和肝癌。它包括生物化學檢驗、診斷影像技術和分子診斷，對於早期疾病檢測、監測進展和評估治療效果至關重要。由於飲酒、肥胖和病毒感染等因素導致肝病盛行率不斷增加，因此需要進行此類診斷。該市場針對醫院、診斷實驗室和研究機構等醫療保健環境，並強調對個人化醫療和非侵入性技術不斷成長的需求作為關鍵應用。

主要市場統計
基準年[2023] 99.4億美元
預測年份 [2024] 110.9億美元
預測年份 [2030] 230.5億美元
複合年成長率（%） 12.76%

影響市場的主要成長要素包括技術進步、對肝病認知的提高以及對準確診斷的需求激增。基因組學和蛋白​​質組學的創新為更準確的診斷鋪平了道路，並增加了標靶治療的潛力。隨著人工智慧主導的診斷工具的發展，最近出現了一些趨勢，這些工具提高了準確性並加快了診斷過程。此外，生物技術公司和醫療保健提供者之間的合作正在促進新診斷解決方案的快速開發和實施。

引進挑戰包括先進診斷測試的高成本、熟練專業人員的有限性以及減緩新技術採用的監管障礙。製藥公司還必須考慮習慣於既定診斷方法的臨床社群的潛在阻力。為了最佳化成長，創新應著重於經濟高效、準確且易於部署的診斷工具。將肝臟微型RNA作為生物標記進行研究、改進成像技術以及用於資料分析的機器學習應用程式是業務擴展的有希望的途徑。

總而言之，由於技術進步和對精準醫療日益成長的需求，肝病診斷市場具有巨大的成長潛力。透過解決成本和監管挑戰以及投資尖端研究，公司可以抓住新機會並鞏固其市場地位。

市場動態：快速發展的肝病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變肝病診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 急性和慢性肝病盛行率增加
    • 制定政府和非政府意識計劃
    • 消費者對微創診斷系統的傾向
  • 市場限制因素
    • 診斷設備高成本且缺乏熟練的專業人員
  • 市場機會
    • 診斷系統的技術進步
    • 改善經濟體的醫療保健可近性
  • 市場挑戰
    • 肝臟診斷系統的複雜性

波特五力策略工具引領肝病診斷市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對肝病診斷市場的影響

外部宏觀環境因素在塑造肝病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解肝病診斷市場的競爭狀況

肝病診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣肝病診斷市場供應商績效評估

FPNV定位矩陣是評估肝病診斷市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 急性和慢性肝病盛行率增加
      • 制定政府和非政府意識計劃
      • 消費者對微創診斷系統的趨勢
    • 抑制因素
      • 診斷設備高成本且缺乏熟練的專業人員
    • 機會
      • 診斷系統的技術進步
      • 改善經濟中的醫療保健服務
    • 任務
      • 與肝臟診斷系統相關的複雜性
  • 市場區隔分析
    • 診斷技術：改善肝臟疾病診斷影像方法的持續進展
    • 最終用戶：政府努力建立強大的醫療基礎設施，擴大了世界各地的醫院規模
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依診斷技術分類的肝病診斷藥物市場

  • 切片檢查
  • 內視鏡檢查
  • 影像
  • 臨床檢查

第7章肝病診斷市場：依最終使用者分類

  • 醫院
  • 研究所

第8章北美、南美洲肝病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區肝病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的肝病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • E-Spicics 開始在美國商業銷售肝臟內視鏡，並在美國開設子公司。
    • Stone Diagnostics 提供纖維化肝病檢測
    • 預測健康情報推出針對未確診肝病的工具

公司名單

  • Abbott Laboratories
  • Bayer AG
  • Merck & Co., Inc.
  • Boston Scientific Corporation
  • Randox Laboratories Ltd.
  • Fujifilm Holdings Corporation
  • Perspectum Ltd.
  • Koninklijke Philips NV
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Laboratory Corporation of America Holdings
  • BioMerieux SA
  • Cook Medical Incorporated
  • Siemens Healthineers AG
  • Horiba, Ltd.
  • Becton, Dickinson and Company
  • Ri.Mos. Srl
  • Hepatiq, Inc.
  • Hologic, Inc.
  • Argon Medical Devices, Inc.
  • Epigenomics AG
  • Medtronic PLC
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
Product Code: MRR-B9334AD6C587

The Liver Disease Diagnostics Market was valued at USD 9.94 billion in 2023, expected to reach USD 11.09 billion in 2024, and is projected to grow at a CAGR of 12.76%, to USD 23.05 billion by 2030.

The Liver Disease Diagnostics market focuses on tools and tests to diagnose liver diseases, including hepatitis, cirrhosis, and liver cancer. It involves biochemical tests, imaging techniques, and molecular diagnostics, essential for early disease detection, monitoring progression, and assessing treatment efficacy. The necessity of such diagnostics lies in the increasing prevalence of liver diseases driven by factors like alcohol consumption, obesity, and viral infections. The market serves healthcare settings, including hospitals, diagnostic labs, and research institutes, emphasizing personalized medicine and the rising demand for non-invasive techniques as critical applications.

KEY MARKET STATISTICS
Base Year [2023] USD 9.94 billion
Estimated Year [2024] USD 11.09 billion
Forecast Year [2030] USD 23.05 billion
CAGR (%) 12.76%

Key growth factors influencing the market include advancements in technology, increasing awareness of liver conditions, and burgeoning demand for accurate diagnostic procedures. Innovations in genomics and proteomics are paving the way for more precise diagnostics, enhancing the potential for targeted therapies. Recent opportunities are emerging in the development of AI-driven diagnostic tools that improve accuracy and speed up the diagnostic process. Additionally, collaborations between biotech firms and healthcare providers are fostering the rapid development and adoption of novel diagnostic solutions.

Challenges include the high cost of advanced diagnostic tests, limited availability of skilled professionals, and regulatory hurdles that can slow down the introduction of new technologies. Pharmaceutical companies must also consider the potential resistance from a clinical community accustomed to established diagnostic methods. To optimize growth, innovation should focus on cost-effective, highly accurate, and easily deployable diagnostic tools. Research into liver microRNA as biomarkers, improved imaging technologies, and machine learning applications for data analysis are promising avenues for business expansion.

In essence, the liver disease diagnostics market holds significant growth potential, driven by technological advancements and an increasing need for precision medicine. By addressing cost and regulatory challenges and investing in cutting-edge research, companies can capture emerging opportunities and strengthen their market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liver Disease Diagnostics Market

The Liver Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the Prevalence of Acute and Chronic Liver Diseases
    • Development of Government and Non-Government Awareness Programs
    • Consumer Inclination Towards Minimally Invasive Diagnostic Systems
  • Market Restraints
    • High Cost of Diagnostic Devices and Lack of Skilled Professionals
  • Market Opportunities
    • Technological Advancements in Diagnostic Systems
    • Improving Healthcare Access in Economies
  • Market Challenges
    • Complexity Associated with Liver Diagnostic Systems

Porter's Five Forces: A Strategic Tool for Navigating the Liver Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liver Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liver Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liver Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liver Disease Diagnostics Market

A detailed market share analysis in the Liver Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liver Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liver Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Liver Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Boston Scientific Corporation, Randox Laboratories Ltd., Fujifilm Holdings Corporation, Perspectum Ltd., Koninklijke Philips N.V., Amgen Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, BioMerieux SA, Cook Medical Incorporated, Siemens Healthineers AG, Horiba, Ltd., Becton, Dickinson and Company, Ri.Mos. Srl, Hepatiq, Inc., Hologic, Inc., Argon Medical Devices, Inc., Epigenomics AG, Medtronic PLC, Thermo Fisher Scientific, Inc., and Quest Diagnostics Incorporated.

Market Segmentation & Coverage

This research report categorizes the Liver Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diagnosis Technique, market is studied across Biopsy, Endoscopy, Imaging, and Laboratory Tests.
  • Based on End-user, market is studied across Hospitals and Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Prevalence of Acute and Chronic Liver Diseases
      • 5.1.1.2. Development of Government and Non-Government Awareness Programs
      • 5.1.1.3. Consumer Inclination Towards Minimally Invasive Diagnostic Systems
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Diagnostic Devices and Lack of Skilled Professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Diagnostic Systems
      • 5.1.3.2. Improving Healthcare Access in Economies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity Associated with Liver Diagnostic Systems
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diagnosis Technique: Ongoing advances to improve imaging modalities for liver disease diagnosis
    • 5.2.2. End-user: Expansion of hospitals across the world supported by government initiatives for developing robust healthcare infrastructure
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Liver Disease Diagnostics Market, by Diagnosis Technique

  • 6.1. Introduction
  • 6.2. Biopsy
  • 6.3. Endoscopy
  • 6.4. Imaging
  • 6.5. Laboratory Tests

7. Liver Disease Diagnostics Market, by End-user

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Laboratories

8. Americas Liver Disease Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Liver Disease Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Liver Disease Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. E-Scopics Announces Commercial Launch Of Hepatoscope in the Us And Opens its Subsidiary in the US
    • 11.3.2. Stone Diagnostics to Provide Fibronostics Liver Disease Test
    • 11.3.3. Predictive Health Intelligence Launches Tool For Undiagnosed Liver Disease

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bayer AG
  • 3. Merck & Co., Inc.
  • 4. Boston Scientific Corporation
  • 5. Randox Laboratories Ltd.
  • 6. Fujifilm Holdings Corporation
  • 7. Perspectum Ltd.
  • 8. Koninklijke Philips N.V.
  • 9. Amgen Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Bio-Rad Laboratories, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. BioMerieux SA
  • 14. Cook Medical Incorporated
  • 15. Siemens Healthineers AG
  • 16. Horiba, Ltd.
  • 17. Becton, Dickinson and Company
  • 18. Ri.Mos. Srl
  • 19. Hepatiq, Inc.
  • 20. Hologic, Inc.
  • 21. Argon Medical Devices, Inc.
  • 22. Epigenomics AG
  • 23. Medtronic PLC
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Quest Diagnostics Incorporated

LIST OF FIGURES

  • FIGURE 1. LIVER DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVER DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVER DISEASE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023